1. Home
  2. Analysis
  3. Erythromycin
  4. Zerit

Erythromycin and Zerit drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Erythromycin (erythromycin) and Zerit (stavudine). Common drug interactions include lactic acidosis among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Erythromycin and Zerit. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Erythromycin?

Erythromycin has active ingredients of erythromycin. It is often used in acne. eHealthMe is studying from 12,563 Erythromycin users. Check the latest studies of Erythromycin.

What is Zerit?

Zerit has active ingredients of stavudine. eHealthMe is studying from 9,912 Zerit users. Check the latest studies of Zerit.

On May, 28, 2026

27 people who take Erythromycin and Zerit together, and have interactions are studied.

Erythromycin and Zerit drug interactions.

What are the common drug interactions of Erythromycin and Zerit, by gender? *:

female:

  1. Lactic acidosis (low ph in body tissues)
  2. Nausea (feeling of having an urge to vomit)
  3. Pregnancy
  4. Thrombocythaemia (an increased number of platelets in the circulating blood)
  5. Urinary tract infection
  6. Vomiting
  7. Acetoacetate increased
  8. Aphagia (inability or refusal to swallow)
  9. Asthma
  10. Blood ketone body increased

male:

  1. Emotional distress
  2. Pain
  3. Multiple fractures
  4. Osteopenia (a condition where bone mineral density is lower than normal)
  5. Renal impairment (severely reduced kidney function)
  6. Weight decreased
  7. Bone pain
  8. Cachexia (loss of weight)
  9. Chronic kidney disease
  10. Coronary artery thrombosis (clot formation in coronary artery)

What are the common drug interactions of Erythromycin and Zerit, by age (0-1 to 60+)? *:

0-1:

  1. Hypertriglyceridaemia (excess of triglycerides in the blood)
  2. Neutropenia neonatal (an abnormally low number of neutrophils in below a month baby)
  3. Blood creatine phosphokinase increased
  4. Blood lactic acid increased
  5. Complications of maternal exposure to therapeutic drugs
  6. Hyperkalaemia (damage to or disease of the kidney)
  7. Macrocytosis (enlargement of red blood cells with near-constant haemoglobin concentration)
  8. Neonatal disorder (disease of neonates)
  9. Thrombocythaemia (an increased number of platelets in the circulating blood)
  10. Acetoacetate increased

2-9:

  1. Blood glucose decreased
  2. Blood lactic acid increased
  3. Hyperkalaemia (damage to or disease of the kidney)
  4. Hypertriglyceridaemia (excess of triglycerides in the blood)
  5. Macrocytosis (enlargement of red blood cells with near-constant haemoglobin concentration)
  6. Neonatal disorder (disease of neonates)
  7. Neutropenia neonatal (an abnormally low number of neutrophils in below a month baby)
  8. Platelet count increased
  9. Tremor neonatal (excited neuromuscular activity of newborns)
  10. Blood creatine phosphokinase increased

10-19:

n/a

20-29:

  1. Calculus urinary (stone in urinary system)
  2. Haematuria present (presence of blood in urine due to trauma)
  3. Urine analysis abnormal

30-39:

  1. Vomiting
  2. Diarrhoea
  3. Cachexia (loss of weight)
  4. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  5. Lactic acidosis (low ph in body tissues)
  6. Nausea (feeling of having an urge to vomit)
  7. Urinary tract infection
  8. Blood alkaline phosphatase nos increased
  9. Blood lactate dehydrogenase increased
  10. Cardiac failure congestive

40-49:

  1. Drug hypersensitivity
  2. Dyspnoea (difficult or laboured respiration)
  3. Weight decreased
  4. Coronary artery thrombosis (clot formation in coronary artery)
  5. Carotid artery thrombosis (blood clot in carotid artery)
  6. Chest pain
  7. Coronary artery embolism (blockage of artery of heart)
  8. Eating disorder
  9. Heart rate decreased
  10. Heart rate increased

50-59:

  1. Bone density decreased
  2. Chronic kidney disease
  3. Emotional distress
  4. Exercise tolerance decreased
  5. Foot fracture
  6. Lumbar vertebral fracture
  7. Mobility decreased (ability to move is reduced)
  8. Multiple fractures
  9. Myelitis (infection or the inflammation of white matter or gray matter of spinal cord which is a part of central nervous system)
  10. Osteoarthritis (a joint disease caused by cartilage loss in a joint)

60+:

  1. Upper limb fracture
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Blood cholesterol increased
  4. Blood creatinine increased
  5. Bone density decreased
  6. Coombs direct test positive
  7. Dyspnoea (difficult or laboured respiration)
  8. Fall
  9. Fear
  10. Foot fracture

What are the existing conditions these people have? *

  1. Hiv Infection: 11 people, 40.74%

* Approximation only. Some reports may have incomplete information.

Do you take Erythromycin and Zerit?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Erythromycin and Zerit:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Erythromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zerit:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Erythromycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zerit and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on erythromycin and stavudine (the active ingredients of Erythromycin and Zerit, respectively), and Erythromycin and Zerit (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.